Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/28351| Title: | Preventing severe chemotherapy-induced reactivation of hepatitis B - Time to adopt a universal approach. | Authors: | Sievert W. | Institution: | (Sievert) Department of Gastroenterology and Hepatology, Monash Medical Centre and Monash University, Melbourne, VIC, Australia | Issue Date: | 28-Jan-2013 | Copyright year: | 2012 | Publisher: | Current Medicine Group LLC (400 Market St, Ste 700 Philadelphia PA 19106, United States) | Place of publication: | United States | Publication information: | Current Hepatitis Reports. 11 (4) (pp 195-196), 2012. Date of Publication: December 2012. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1007/s11901-012-0150-6 | ISSN: | 1540-3416 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/28351 | Type: | Note | Subjects: | screening *virus reactivation virus replication entecavir/dt [Drug Therapy] hepatitis B core antibody/ec [Endogenous Compound] hepatitis B surface antigen/ec [Endogenous Compound] lamivudine/dt [Drug Therapy] rituximab/ae [Adverse Drug Reaction] rituximab/dt [Drug Therapy] tenofovir/dt [Drug Therapy] tumor necrosis factor alpha inhibitor *hepatitis B/pc [Prevention] antiviral therapy *cancer chemotherapy hepatitis B/dt [Drug Therapy] *hepatitis B/dt [Drug Therapy] human immune deficiency/si [Side Effect] immunosuppressive treatment infection prevention lymphoma/dt [Drug Therapy] note note screening *virus reactivation virus replication *cancer chemotherapy antiviral therapy hepatitis B / drug therapy *hepatitis B / *drug therapy / *prevention human immune deficiency / side effect immunosuppressive treatment infection prevention lymphoma / drug therapy |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.